Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Chemical health hazard testing is a systematic scientific process used to evaluate the potential adverse effects of chemical substances on human health, covering endpoints such as acute toxicity, skin corrosion, eye irritation, sensitization, mutagenicity, and reproductive toxicity. Guided by internationally recognized frameworks including the GHS, OECD Test Guidelines, and national standards such as GB 30000 series, this testing forms the foundation for hazard classification, labeling, and safe chemical management worldwide. This article provides a comprehensive technical overview of chemical health hazard testing, including sample types, test items, methodologies, and typical industrial applications.

Technical Overview

Chemical health hazard testing refers to the battery of laboratory evaluations designed to identify and characterize the intrinsic harmful properties of chemical substances toward human health. The results of these tests determine how a substance is classified under regulatory schemes such as the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), the EU REACH Regulation, and China's GB 30000 series national standards for chemical classification. Health hazard endpoints defined by GHS include acute toxicity, skin corrosion and irritation, serious eye damage and eye irritation, respiratory or skin sensitization, germ cell mutagenicity, carcinogenicity, reproductive toxicity, specific target organ toxicity (single and repeated exposure), and aspiration hazard.

Modern chemical health hazard testing follows a tiered and weight-of-evidence strategy. Testing begins with existing data evaluation, in silico approaches such as QSAR modeling and read-across, followed by in vitro methods using reconstructed human tissues and cell cultures, and, only when necessary, confirmatory in vivo studies conducted under strict animal welfare principles. The OECD Test Guidelines program and IATA (Integrated Approaches to Testing and Assessment) provide the internationally harmonized methodological basis. Accredited third-party laboratories performing these tests must operate under GLP (Good Laboratory Practice) compliance to ensure data quality and mutual acceptance across jurisdictions that are members of the OECD MAD (Mutual Acceptance of Data) agreement.

Testing Samples

Industrial Chemicals and Intermediates

Raw materials, reaction intermediates, solvents, monomers, catalysts, and process chemicals require health hazard evaluation for registration under regulations such as REACH, China's Measures for Environmental Management of New Chemical Substances (MEE Order No. 12), and Korea's K-REACH. Both new chemical substances and existing chemicals subject to re-evaluation fall within this category.

Consumer and Household Products

Cleaning agents, detergents, air fresheners, adhesives, paints, coatings, cosmetics ingredients, and textile auxiliaries are tested to assess consumer exposure risks. These products often require classification according to GB/T 36423 or analogous national consumer chemical safety standards before market placement.

Agrochemicals and Biocides

Pesticide active ingredients and formulations, fertilizers, disinfectants, and preservatives undergo extensive toxicological profiling, including acute toxicity packages, dermal sensitization, and long-term studies, to support registration dossiers under pesticide management regulations.

Pharmaceutical, Food Contact, and Specialty Materials

Pharmaceutical impurities, food contact materials, food additives, flavor and fragrance substances, electronic chemicals, and battery electrolytes require targeted hazard evaluation relevant to their exposure scenarios and applicable frameworks such as ISO 10993 for medical device biocompatibility and relevant EN food contact standards.

Testing Items

Chemical health hazard testing encompasses a structured set of toxicological endpoints aligned with GHS hazard classes. Typical test items include:

  • Acute toxicity: oral, dermal, and inhalation routes, expressed as LD50 or LC50 values, classified into GHS Categories 1 through 5
  • Skin corrosion and irritation: evaluated via skin corrosion studies and skin irritation studies producing classification such as Category 1 (corrosive), Category 2 (irritant), or Category 3 (mild irritant)
  • Serious eye damage and eye irritation: distinguishing irreversible eye effects (Category 1) from reversible irritation (Category 2/2A and 2B)
  • Skin sensitization and respiratory sensitization: identification of substances capable of inducing allergic responses
  • Germ cell mutagenicity: in vitro and in vivo genotoxicity testing including bacterial reverse mutation tests, chromosomal aberration assays, and micronucleus tests
  • Carcinogenicity: long-term studies or weight-of-evidence assessment based on structure-activity relationships and available data
  • Reproductive toxicity: effects on fertility, sexual function, and development, including CMR (carcinogenic, mutagenic, repro-toxic) classification
  • Specific target organ toxicity (STOT): single-exposure and repeated-dose toxicity with NOAEL and LOAEL determination, typically based on 28-day and 90-day studies
  • Aspiration hazard: assessment based on viscosity and kinetic behavior for hydrocarbon-based substances

Testing Methods

Testing is conducted according to internationally harmonized protocols. The principal method families are summarized below.

In Vivo Acute and Systemic Toxicity Methods

Acute oral toxicity is determined using the Acute Toxic Class Method (OECD TG 423) or the Up-and-Down Procedure (OECD TG 425), which substantially reduce animal usage compared to classical LD50 protocols. Corresponding Chinese national standards include the GB/T 21604 and GB/T 21804 series. Acute dermal toxicity (OECD TG 402) and acute inhalation toxicity (OECD TG 403, 436) complete the route-specific picture.

In Vitro Alternatives for Local Toxicity

Skin corrosion is assessed using reconstructed human epidermis models under OECD TG 431, the transcutaneous electrical resistance test under OECD TG 430, or the CORROSITEX membrane barrier test under OECD TG 435. Skin irritation is evaluated with reconstructed epidermis models per OECD TG 439. Eye hazard assessment uses the Bovine Corneal Opacity and Permeability test (OECD TG 437), the Isolated Chicken Eye test (OECD TG 438), or reconstructed human cornea-like epithelium models per OECD TG 492. These in vitro methods are widely accepted as full replacements for animal testing in relevant hazard categories under both EU and Chinese regulations.

Sensitization Testing Strategies

Skin sensitization follows defined approaches combining chemical and in vitro information, such as the DPRA (Direct Peptide Reactivity Assay, OECD TG 442C), KeratinoSens or LuSens assays (OECD TG 442D), and human cell line activation tests (OECD TG 442E), integrated per the OECD Guiding Document on IATA. Where in vivo confirmation is still required, the Local Lymph Node Assay (OECD TG 429) or the Guinea Pig Maximization Test (OECD TG 406) may be applied.

Genotoxicity and Repeated-Dose Studies

Standard mutagenicity batteries include the bacterial reverse mutation test (OECD TG 471), in vitro mammalian chromosomal aberration test (OECD TG 473), and in vitro mammalian cell gene mutation tests (OECD TG 476 or 490), with in vivo follow-up using the mammalian erythrocyte micronucleus test (OECD TG 474). Subchronic systemic toxicity is examined through 28-day repeated-dose studies (OECD TG 407) and 90-day studies (OECD TG 408), which underpin STOT-RE classification and derived no-effect level calculations.

Computational and Weight-of-Evidence Approaches

Where testing can be avoided, QSAR predictions validated under OECD QSAR validation principles, read-across from structurally analogous substances, and category approaches provide hazard information acceptable under REACH and Chinese new chemical notification schemes. Grouping justifications must document structural similarity, mechanistic plausibility, and data adequacy.

Applications

Chemical health hazard testing results directly support multiple regulatory and commercial objectives:

  • GHS classification and preparation of labels, safety data sheets (SDS) compliant with GB/T 16483, ISO 11014, and UN GHS Purple Book revisions
  • Registration and notification of new chemical substances under China MEE Order No. 12, EU REACH, US TSCA, and K-REACH
  • Hazard communication for workplace safety programs aligned with occupational exposure limit setting and risk assessment
  • Transportation classification determining packing groups for dangerous goods under UN Model Regulations and relevant transport codes
  • Product stewardship, green chemistry substitution programs, and restricted substance compliance screening
  • Support for customs clearance, tender documentation, and supply chain qualification requiring verified toxicological data

FAQ

What is the difference between health hazard testing and physicochemical hazard testing?

Health hazard testing evaluates toxicological effects on humans, such as toxicity, irritation, sensitization, and mutagenicity, whereas physicochemical hazard testing covers flammability, explosivity, oxidizing properties, and self-reactive behavior. Both categories are required for complete GHS classification of a chemical substance.

Are animal tests still mandatory for chemical health hazard assessment?

No. Regulatory frameworks increasingly prioritize alternatives. Validated in vitro methods under OECD Test Guidelines are accepted as standalone evidence for skin corrosion, skin irritation, and serious eye damage classification. Testing strategies should follow the 3Rs principles (replacement, reduction, refinement) and existing data must always be reviewed before initiating new studies.

How long does a typical acute toxicity test take?

An acute oral toxicity study using OECD TG 423 typically requires two to four weeks of laboratory execution, including observation periods, followed by several weeks for report finalization. Overall project timelines depend on scheduling, substance properties, and any required analytical verification of test item stability.

Which reports or deliverables are produced after testing?

GLP-compliant study reports provide raw data, methodology, results, and classification conclusions. These reports support the preparation or updating of safety data sheets, GHS labels, and regulatory dossiers. Accredited third-party laboratories also issue statements of conformity when only classification verification against specific standards is needed.

How are test substances with limited solubility or volatility handled?

Special formulation, exposure chamber engineering, and analytical monitoring are applied for poorly soluble or volatile substances, particularly in inhalation studies. Test facility protocols under OECD guidance define maximum achievable concentrations and justification documentation for such cases.